Brokerage house Macquarie said Asian investors prefer mid-cap pharma companies over their larger counterparts where they remain cautious. Most investors are wary of investing in the U.S. centric large-cap stocks after the massive stock price correction over the last one-and-a-half to two years, the ...
Read more: Investors Prefer Mid Caps Over Large Caps In Indian Pharma Sector, Macquarie Says